(+)-epicatechin-3-O-gallate increases expression EXP 6480464 epicatechin gallate results in increased expression of NR0B2 mRNA CTD PMID:22178739 (+)-schisandrin B multiple interactions ISO RGD:621032 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NR0B2 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of NR0B2 mRNA], epigallocatechin gallate inhibits the reaction [GW 4064 results in increased expression of NR0B2 mRNA] CTD PMID:22178739 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:621032 6480464 epigallocatechin gallate results in decreased expression of NR0B2 mRNA CTD PMID:23146761 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732874 6480464 NR1H4 protein affects the reaction [epigallocatechin gallate results in increased expression of NR0B2 mRNA] CTD PMID:22178739 (-)-epigallocatechin 3-gallate increases expression ISO RGD:732874 6480464 epigallocatechin gallate results in increased expression of NR0B2 mRNA CTD PMID:22178739 (-)-epigallocatechin 3-gallate increases expression EXP 6480464 epigallocatechin gallate results in increased expression of NR0B2 mRNA CTD PMID:22178739 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression EXP 6480464 chlorcyclizine results in increased expression of NR0B2 mRNA CTD PMID:15342952 1-naphthyl isothiocyanate multiple interactions ISO RGD:732874 6480464 [NR1H4 protein results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of NR0B2 mRNA more ... CTD PMID:19181614 more ... 1-naphthyl isothiocyanate decreases expression ISO RGD:621032 6480464 1-Naphthylisothiocyanate results in decreased expression of NR0B2 mRNA CTD PMID:30723492 1-naphthyl isothiocyanate decreases expression ISO RGD:732874 6480464 1-Naphthylisothiocyanate results in decreased expression of NR0B2 protein CTD PMID:32579994 1-naphthyl isothiocyanate increases expression ISO RGD:621032 6480464 1-Naphthylisothiocyanate results in increased expression of NR0B2 mRNA CTD PMID:27317372 1-naphthyl isothiocyanate multiple interactions ISO RGD:621032 6480464 dioscin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of NR0B2 mRNA] CTD PMID:27317372 1-naphthyl isothiocyanate increases expression ISO RGD:732874 6480464 1-Naphthylisothiocyanate results in increased expression of NR0B2 mRNA CTD PMID:19181614 , PMID:25655198 1-naphthyl isothiocyanate multiple interactions EXP 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of NR0B2 mRNA CTD PMID:27344345 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of NR0B2 mRNA CTD PMID:17175557 17alpha-ethynylestradiol increases expression ISO RGD:732874 6480464 Ethinyl Estradiol results in increased expression of NR0B2 mRNA CTD PMID:29112739 17alpha-ethynylestradiol decreases expression ISO RGD:621032 6480464 Ethinyl Estradiol results in decreased expression of NR0B2 mRNA CTD PMID:23146761 17alpha-ethynylestradiol increases expression ISO RGD:621032 6480464 Ethinyl Estradiol results in increased expression of NR0B2 mRNA CTD PMID:16487557 , PMID:17108234 17alpha-ethynylestradiol multiple interactions ISO RGD:732874 6480464 [Ethinyl Estradiol co-treated with ESR1 protein] inhibits the reaction [IL1B protein results in increased expression of NR0B2 mRNA] more ... CTD PMID:12072388 more ... 17beta-estradiol multiple interactions EXP 6480464 Estradiol affects the reaction [ESR1 protein binds to NR0B2 protein] CTD PMID:29389661 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions EXP 6480464 [Metribolone binds to and affects the folding of AR protein] affects the reaction [AR protein modified form binds to NR0B2 protein modified form] CTD PMID:28751236 2,2',4,4',5,5'-hexachlorobiphenyl increases activity EXP 6480464 2 more ... CTD PMID:27589886 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:732874 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732874 6480464 Tetrachlorodibenzodioxin affects the expression of NR0B2 mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732874 6480464 Tetrachlorodibenzodioxin results in increased expression of NR0B2 mRNA CTD PMID:29452137 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 NR0B2 protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA], NR0B2 protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT1A6 mRNA] CTD PMID:11368516 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:621032 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR0B2 mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR0B2 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:621032 6480464 Tetrachlorodibenzodioxin results in increased expression of NR0B2 mRNA CTD PMID:20558275 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732874 6480464 [AHR gene mutant form affects the susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NR0B2 mRNA more ... CTD PMID:17942748 , PMID:29452137 2,3,7,8-Tetrachlorodibenzofuran multiple interactions ISO RGD:732874 6480464 AHR protein promotes the reaction [2 more ... CTD PMID:25768209 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:732874 6480464 2 more ... CTD PMID:25768209 2,4-dinitrotoluene affects expression ISO RGD:621032 6480464 2, 4-dinitrotoluene affects the expression of NR0B2 mRNA CTD PMID:21346803 2-butoxyethanol decreases expression ISO RGD:732874 6480464 n-butoxyethanol results in decreased expression of NR0B2 mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:621032 6480464 3 more ... CTD PMID:20959002 3,3',5-triiodo-L-thyronine increases expression ISO RGD:621032 6480464 Triiodothyronine results in increased expression of NR0B2 mRNA CTD PMID:29357290 3-chloropropane-1,2-diol decreases expression ISO RGD:621032 6480464 alpha-Chlorohydrin results in decreased expression of NR0B2 mRNA CTD PMID:28522335 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of NR0B2 mRNA CTD PMID:19118567 3H-1,2-dithiole-3-thione decreases expression ISO RGD:621032 6480464 1, 2-dithiol-3-thione results in decreased expression of NR0B2 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO RGD:732874 6480464 4, 4'-diaminodiphenylmethane results in increased expression of NR0B2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 bis4-hydroxyphenylsulfone promotes the reaction [ESR1 protein binds to NR0B2 protein] CTD PMID:29389661 4,4'-sulfonyldiphenol increases expression ISO RGD:732874 6480464 bis4-hydroxyphenylsulfone results in increased expression of NR0B2 mRNA CTD PMID:30145421 4-amino-2,6-dinitrotoluene affects expression ISO RGD:621032 6480464 4-amino-2, 6-dinitrotoluene affects the expression of NR0B2 mRNA CTD PMID:21346803 Actein decreases expression ISO RGD:621032 6480464 actein results in decreased expression of NR0B2 protein CTD PMID:29969672 actinomycin D multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [Fenofibrate results in increased expression of NR0B2 mRNA] CTD PMID:19593819 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of NR0B2 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of NR0B2 mRNA CTD PMID:21632981 AICA ribonucleotide decreases expression ISO RGD:732874 6480464 AICA ribonucleotide results in decreased expression of NR0B2 mRNA CTD PMID:24428821 aldehydo-D-glucose multiple interactions EXP 6480464 [[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose CTD PMID:22062806 all-trans-retinoic acid affects metabolic processing ISO RGD:732874 6480464 NR0B2 protein affects the metabolism of Tretinoin CTD PMID:17289919 all-trans-retinoic acid increases expression ISO RGD:621032 6480464 Tretinoin results in increased expression of NR0B2 mRNA CTD PMID:21274875 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of NR0B2 mRNA, Tretinoin results in increased expression of NR0B2 protein CTD PMID:21274875 , PMID:30709899 amitriptyline increases expression EXP 6480464 Amitriptyline results in increased expression of NR0B2 mRNA CTD PMID:15342952 , PMID:17175557 ammonium chloride affects expression ISO RGD:621032 6480464 Ammonium Chloride affects the expression of NR0B2 mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Fenofibrate results in increased expression of NR0B2 mRNA] CTD PMID:19593819 antimony(0) decreases expression EXP 6480464 Antimony results in decreased expression of NR0B2 mRNA CTD PMID:17547211 atorvastatin calcium decreases expression ISO RGD:732874 6480464 Atorvastatin results in decreased expression of NR0B2 mRNA CTD PMID:25278499 benzo[a]pyrene increases expression ISO RGD:732874 6480464 Benzoapyrene results in increased expression of NR0B2 mRNA CTD PMID:20127859 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of NR0B2 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation EXP 6480464 Benzoapyrene affects the methylation of NR0B2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of NR0B2 mRNA CTD PMID:21632981 , PMID:26238291 benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:26238291 bexarotene increases expression ISO RGD:621032 6480464 bexarotene results in increased expression of NR0B2 mRNA CTD PMID:17630414 , PMID:23292798 bexarotene increases expression EXP 6480464 Bexarotene results in increased expression of NR0B2 mRNA CTD PMID:32123961 bexarotene multiple interactions EXP 6480464 [Bexarotene co-treated with GW 3965] results in increased expression of NR0B2 mRNA more ... CTD PMID:32123961 bezafibrate increases expression ISO RGD:732874 6480464 Bezafibrate results in increased expression of NR0B2 mRNA CTD PMID:19124612 bezafibrate multiple interactions ISO RGD:732874 6480464 PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of NR0B2 mRNA] CTD PMID:19124612 bis(2-ethylhexyl) phthalate increases expression ISO RGD:732874 6480464 Diethylhexyl Phthalate results in increased expression of NR0B2 mRNA CTD PMID:25975992 bisphenol A affects expression ISO RGD:621032 6480464 bisphenol A affects the expression of NR0B2 mRNA CTD PMID:25181051 , PMID:30903817 bisphenol A increases expression ISO RGD:732874 6480464 bisphenol A results in increased expression of NR0B2 mRNA CTD PMID:30145421 bisphenol A affects methylation ISO RGD:732874 6480464 bisphenol A affects the methylation of NR0B2 promoter CTD PMID:27334623 bisphenol A multiple interactions EXP 6480464 [bisphenol A binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to NR0B2 protein modified form], bisphenol A affects the reaction [ESR1 protein binds to NR0B2 protein] CTD PMID:28751236 , PMID:29389661 Boldine increases expression ISO RGD:621032 6480464 boldine results in increased expression of NR0B2 mRNA CTD PMID:25771127 calcipotriol increases expression EXP 6480464 calcipotriene results in increased expression of NR0B2 protein CTD PMID:30419252 calcium atom affects expression ISO RGD:621032 6480464 Calcium affects the expression of NR0B2 mRNA CTD PMID:15913539 calcium(0) affects expression ISO RGD:621032 6480464 Calcium affects the expression of NR0B2 mRNA CTD PMID:15913539 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of NR0B2 mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO RGD:732874 6480464 Nanotubes more ... CTD PMID:25620056 chenodeoxycholic acid increases expression EXP 6480464 Chenodeoxycholic Acid results in increased expression of NR0B2 mRNA CTD PMID:16037943 more ... chenodeoxycholic acid increases expression ISO RGD:732874 6480464 Chenodeoxycholic Acid results in increased expression of NR0B2 mRNA CTD PMID:16946559 more ... chenodeoxycholic acid multiple interactions ISO RGD:732874 6480464 NR1H4 protein promotes the reaction [Chenodeoxycholic Acid results in increased expression of NR0B2 mRNA] CTD PMID:16946559 chenodeoxycholic acid multiple interactions ISO RGD:621032 6480464 [Chenodeoxycholic Acid binds to NR1H4 protein] which results in increased expression of NR0B2 mRNA CTD PMID:19562681 chenodeoxycholic acid increases expression ISO RGD:621032 6480464 Chenodeoxycholic Acid results in increased expression of NR0B2 mRNA CTD PMID:15980055 more ... chenodeoxycholic acid multiple interactions EXP 6480464 7-hydroxytheonellasterol inhibits the reaction [Chenodeoxycholic Acid results in increased expression of NR0B2 mRNA] more ... CTD PMID:17963371 more ... chlorohydrocarbon multiple interactions ISO RGD:621032 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of NR0B2 mRNA CTD PMID:30744511 chloroquine decreases expression ISO RGD:732874 6480464 Chloroquine results in decreased expression of NR0B2 mRNA CTD PMID:24189133 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of NR0B2 mRNA CTD PMID:17175557 cholic acid increases expression EXP 6480464 Cholic Acid results in increased expression of NR0B2 mRNA CTD PMID:25055961 cholic acid increases expression ISO RGD:732874 6480464 Cholic Acid results in increased expression of NR0B2 mRNA CTD PMID:12072388 more ... cholic acid increases expression ISO RGD:621032 6480464 Cholic Acid results in increased expression of NR0B2 mRNA CTD PMID:14684380 cholic acid multiple interactions ISO RGD:621032 6480464 [Cholesterol, Dietary co-treated with Cholic Acid] results in increased expression of NR0B2 mRNA CTD PMID:14684380 cholic acid multiple interactions ISO RGD:732874 6480464 [Cholic Acid binds to and results in increased activity of NR1H4 protein] which results in increased expression of NR0B2 mRNA, IL1B protein inhibits the reaction [Cholic Acid results in increased expression of NR0B2 mRNA] CTD PMID:12072388 , PMID:22540009 choline multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of NR0B2 mRNA] more ... CTD PMID:25712622 choline multiple interactions ISO RGD:732874 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Fenofibrate] results in increased expression of NR0B2 mRNA more ... CTD PMID:19593819 , PMID:25712622 chromium atom decreases expression EXP 6480464 Chromium results in decreased expression of NR0B2 mRNA CTD PMID:17547211 ciprofloxacin increases expression ISO RGD:732874 6480464 Ciprofloxacin results in increased expression of NR0B2 mRNA CTD PMID:24657338 clofibrate multiple interactions ISO RGD:732874 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NR0B2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NR0B2 mRNA] CTD PMID:17585979 clofibrate increases expression ISO RGD:732874 6480464 Clofibrate results in increased expression of NR0B2 mRNA CTD PMID:29175453 clofibrate decreases expression ISO RGD:732874 6480464 Clofibrate results in decreased expression of NR0B2 mRNA CTD PMID:28973556 clofibric acid multiple interactions ISO RGD:621032 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NR0B2 mRNA CTD PMID:17602206 clomipramine increases expression EXP 6480464 Clomipramine results in increased expression of NR0B2 mRNA CTD PMID:17175557 clothianidin decreases expression EXP 6480464 clothianidin results in decreased expression of NR0B2 mRNA CTD PMID:32201337 clothianidin multiple interactions EXP 6480464 [clothianidin co-treated with enilconazole] results in decreased expression of NR0B2 mRNA CTD PMID:32201337 clozapine increases expression EXP 6480464 Clozapine results in increased expression of NR0B2 mRNA CTD PMID:15342952 , PMID:17175557 cobalt dichloride decreases expression ISO RGD:621032 6480464 cobaltous chloride results in decreased expression of NR0B2 mRNA CTD PMID:24386269 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of NR0B2 mRNA CTD PMID:19549813 coumarin increases expression ISO RGD:621032 6480464 coumarin results in increased expression of NR0B2 mRNA CTD PMID:18480146 cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of NR0B2 mRNA CTD PMID:27344345 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of NR0B2 mRNA CTD PMID:20106945 more ... cyproterone acetate multiple interactions EXP 6480464 [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to NR0B2 protein modified form] CTD PMID:28751236 D-glucose multiple interactions EXP 6480464 [[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose CTD PMID:22062806 deoxycholic acid increases expression EXP 6480464 Deoxycholic Acid results in increased expression of NR0B2 mRNA CTD PMID:22540009 , PMID:25055961 deoxycholic acid increases expression ISO RGD:621032 6480464 Deoxycholic Acid results in increased expression of NR0B2 mRNA CTD PMID:27743861 deoxycholic acid increases expression ISO RGD:732874 6480464 Deoxycholic Acid results in increased expression of NR0B2 mRNA CTD PMID:25582706 dexamethasone decreases expression ISO RGD:621032 6480464 Dexamethasone results in decreased expression of NR0B2 mRNA CTD PMID:20832446 , PMID:29222744 dexamethasone multiple interactions ISO RGD:732874 6480464 [Dexamethasone co-treated with Ibuprofen] results in decreased expression of NR0B2 mRNA, [Dexamethasone co-treated with Ibuprofen] results in decreased expression of NR0B2 protein CTD PMID:29222744 dibutyl phthalate increases expression ISO RGD:732874 6480464 Dibutyl Phthalate results in increased expression of NR0B2 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:621032 6480464 Dibutyl Phthalate results in decreased expression of NR0B2 mRNA CTD PMID:21266533 dichloroacetic acid decreases expression ISO RGD:732874 6480464 Dichloroacetic Acid results in decreased expression of NR0B2 mRNA CTD PMID:28962523 diclofenac affects expression EXP 6480464 Diclofenac affects the expression of NR0B2 mRNA CTD PMID:24752500 dicrotophos increases expression EXP 6480464 dicrotophos results in increased expression of NR0B2 mRNA CTD PMID:28302478 diethyl maleate decreases expression ISO RGD:621032 6480464 diethyl maleate results in decreased expression of NR0B2 mRNA CTD PMID:21161181 dihydroartemisinin multiple interactions ISO RGD:621032 15036816 Dihydroartemisinin inhibits the reaction [ethanol decreases expression of Nr0b2 protein in liver and intestine] RGD dioscin multiple interactions ISO RGD:621032 6480464 dioscin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of NR0B2 mRNA] CTD PMID:27317372 dioscin increases expression ISO RGD:621032 6480464 dioscin results in increased expression of NR0B2 mRNA CTD PMID:27317372 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression EXP 6480464 Antimony Potassium Tartrate results in decreased expression of NR0B2 mRNA CTD PMID:17547211 disopyramide decreases expression EXP 6480464 Disopyramide results in decreased expression of NR0B2 mRNA CTD PMID:15342952 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Fenofibrate results in increased expression of NR0B2 mRNA] CTD PMID:19593819 emodin increases expression ISO RGD:732874 6480464 Emodin results in increased expression of NR0B2 mRNA CTD PMID:30517764 enilconazole multiple interactions EXP 6480464 [clothianidin co-treated with enilconazole] results in decreased expression of NR0B2 mRNA CTD PMID:32201337 enilconazole decreases expression EXP 6480464 enilconazole results in decreased expression of NR0B2 mRNA CTD PMID:32201337 ethanol multiple interactions ISO RGD:732874 6480464 Ethanol promotes the reaction [NR1H4 gene mutant form results in decreased expression of NR0B2 mRNA] CTD PMID:25460735 ethanol decreases expression ISO RGD:621032 15036816 ethanol decreases expression of Nr0b2 protein in liver and intestine RGD farnesol multiple interactions EXP 6480464 [Farnesol analog co-treated with Oleic Acid] results in decreased expression of NR0B2 mRNA CTD PMID:30611723 farnesol decreases expression EXP 6480464 Farnesol analog results in decreased expression of NR0B2 mRNA CTD PMID:30611723 fenofibrate multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [Fenofibrate results in increased expression of NR0B2 mRNA] more ... CTD PMID:19593819 fenofibrate increases expression ISO RGD:621032 6480464 Fenofibrate results in increased expression of NR0B2 mRNA CTD PMID:19593819 fenofibrate increases expression ISO RGD:732874 6480464 Fenofibrate results in increased expression of NR0B2 mRNA CTD PMID:19593819 fenofibrate multiple interactions ISO RGD:732874 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Fenofibrate] results in increased expression of NR0B2 mRNA more ... CTD PMID:19593819 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of NR0B2 mRNA, Fenofibrate results in increased expression of NR0B2 protein CTD PMID:19593819 fenvalerate decreases expression ISO RGD:621032 6480464 fenvalerate results in decreased expression of NR0B2 mRNA CTD PMID:30307764 fipronil multiple interactions EXP 6480464 [fipronil co-treated with DEET] results in increased expression of NR0B2 mRNA CTD PMID:27091632 flecainide increases expression EXP 6480464 Flecainide results in increased expression of NR0B2 mRNA CTD PMID:17175557 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of NR0B2 mRNA CTD PMID:15342952 , PMID:17175557 flutamide decreases expression ISO RGD:621032 6480464 Flutamide results in decreased expression of NR0B2 mRNA CTD PMID:24136188 fructose multiple interactions ISO RGD:732874 6480464 NR0B2 protein inhibits the reaction [AHR protein results in increased susceptibility to [Dietary Fats co-treated with Fructose]], NR0B2 protein results in decreased susceptibility to [Dietary Fats co-treated with Fructose] CTD PMID:29416063 furan multiple interactions ISO RGD:732874 6480464 rhodioloside inhibits the reaction [furan results in increased expression of NR0B2 mRNA] CTD PMID:32251705 furan increases expression ISO RGD:732874 6480464 furan results in increased expression of NR0B2 mRNA CTD PMID:32251705 gallocatechin increases expression EXP 6480464 gallocatechol results in increased expression of NR0B2 mRNA CTD PMID:22178739 gamma-hexachlorocyclohexane increases expression ISO RGD:621032 6480464 Hexachlorocyclohexane results in increased expression of NR0B2 mRNA CTD PMID:17785943 genistein decreases expression ISO RGD:732874 6480464 Genistein results in decreased expression of NR0B2 mRNA CTD PMID:32186404 ginsenoside Re increases expression EXP 6480464 ginsenoside Re results in increased expression of NR0B2 mRNA CTD PMID:21971952 ginsenoside Rg2 increases expression EXP 6480464 ginsenoside Rg2 results in increased expression of NR0B2 mRNA CTD PMID:22062806 ginsenoside Rg2 increases activity EXP 6480464 ginsenoside Rg2 results in increased activity of NR0B2 protein CTD PMID:22062806 ginsenoside Rg2 multiple interactions EXP 6480464 [[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose, [ginsenoside Rg2 results in increased activity of NR0B2 protein] which results in decreased activity of CRTC2 protein CTD PMID:22062806 glucose multiple interactions EXP 6480464 [[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose CTD PMID:22062806 glutathione increases expression ISO RGD:621032 6480464 Glutathione deficiency results in increased expression of NR0B2 mRNA CTD PMID:15345336 glycyrrhizinic acid increases expression ISO RGD:732874 6480464 Glycyrrhizic Acid results in increased expression of NR0B2 mRNA CTD PMID:22982774 guggulsterone multiple interactions ISO RGD:621032 15036816 Z-guggulsterone reverses the reaction [Dihydroartemisinin inhibits the reaction [ethanol decreases expression of Nr0b2 protein in liver and intestine]] RGD guggulsterone multiple interactions ISO RGD:732874 6480464 pregna-4 more ... CTD PMID:25655198 guggulsterone multiple interactions EXP 6480464 pregna-4 more ... CTD PMID:22414727 GW 3965 increases expression EXP 6480464 GW 3965 results in increased expression of NR0B2 mRNA CTD PMID:32123961 GW 3965 multiple interactions EXP 6480464 [Bexarotene co-treated with GW 3965] results in increased expression of NR0B2 mRNA, [CD 3254 co-treated with GW 3965] results in increased expression of NR0B2 mRNA CTD PMID:32123961 GW 4064 multiple interactions ISO RGD:732874 6480464 [GW 4064 binds to and results in increased activity of NR1H4 protein] which results in increased expression of NR0B2 mRNA more ... CTD PMID:19072826 more ... GW 4064 increases expression EXP 6480464 GW 4064 results in increased expression of NR0B2 mRNA CTD PMID:16269825 more ... GW 4064 multiple interactions EXP 6480464 [GW 4064 binds to and results in increased activity of NR1H4 protein] which results in increased expression of NR0B2 mRNA more ... CTD PMID:22178739 more ... GW 4064 increases expression ISO RGD:621032 6480464 GW 4064 results in increased expression of NR0B2 mRNA CTD PMID:14623915 more ... GW 4064 increases expression ISO RGD:732874 6480464 GW 4064 results in increased expression of NR0B2 mRNA CTD PMID:19072826 more ... GW 7647 multiple interactions EXP 6480464 [GW 7647 co-treated with Oleic Acid] results in decreased expression of NR0B2 mRNA CTD PMID:30611723 GW 7647 decreases expression EXP 6480464 GW 7647 results in decreased expression of NR0B2 mRNA CTD PMID:30611723 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of NR0B2 mRNA CTD PMID:17175557 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of NR0B2 mRNA CTD PMID:23410634 ibuprofen multiple interactions ISO RGD:732874 6480464 [Dexamethasone co-treated with Ibuprofen] results in decreased expression of NR0B2 mRNA, [Dexamethasone co-treated with Ibuprofen] results in decreased expression of NR0B2 protein CTD PMID:29222744 imipenem hydrate multiple interactions ISO RGD:732874 6480464 [Vancomycin co-treated with Imipenem] results in increased expression of NR0B2 mRNA CTD PMID:24657338 imipramine increases expression EXP 6480464 Imipramine results in increased expression of NR0B2 mRNA CTD PMID:15342952 isoniazide multiple interactions EXP 6480464 [Isoniazid co-treated with Vitamin B 6] results in decreased expression of NR0B2 mRNA CTD PMID:32673658 isoniazide decreases expression ISO RGD:621032 6480464 Isoniazid results in decreased expression of NR0B2 mRNA CTD PMID:32673658 isoniazide multiple interactions ISO RGD:621032 6480464 obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of NR0B2 mRNA] CTD PMID:32673658 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of NR0B2 mRNA CTD PMID:15342952 , PMID:17175557 L-methionine multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of NR0B2 mRNA] more ... CTD PMID:25712622 L-methionine multiple interactions ISO RGD:732874 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Fenofibrate] results in increased expression of NR0B2 mRNA more ... CTD PMID:19593819 , PMID:25712622 Lasiocarpine decreases expression EXP 6480464 lasiocarpine results in decreased expression of NR0B2 mRNA CTD PMID:32234424 lead nitrate decreases expression ISO RGD:732874 6480464 lead nitrate results in decreased expression of NR0B2 mRNA CTD PMID:16049268 lead nitrate decreases expression ISO RGD:621032 6480464 lead nitrate results in decreased expression of NR0B2 mRNA CTD PMID:15475176 lipopolysaccharide decreases expression ISO RGD:732874 6480464 Lipopolysaccharides results in decreased expression of NR0B2 mRNA CTD PMID:15312234 , PMID:16002565 lipopolysaccharide multiple interactions ISO RGD:732874 6480464 Lipopolysaccharides promotes the reaction [triptolide results in decreased expression of NR0B2 mRNA] CTD PMID:30633930 lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of NR0B2 mRNA, Lithocholic Acid results in increased expression of NR0B2 protein CTD PMID:19562681 more ... lithocholic acid increases expression ISO RGD:732874 6480464 Lithocholic Acid results in increased expression of NR0B2 mRNA CTD PMID:22982774 , PMID:25582706 lithocholic acid multiple interactions EXP 6480464 [Lithocholic Acid analog binds to and results in increased activity of NR1H4 protein] which results in increased expression of NR0B2 mRNA, [Lithocholic Acid binds to and results in increased activity of NR1H4 protein] which results in increased expression of NR0B2 mRNA CTD PMID:17963371 lithocholic acid multiple interactions ISO RGD:621032 6480464 [Lithocholic Acid binds to VDR protein] which results in increased expression of NR0B2 mRNA CTD PMID:19562681 lithocholic acid decreases expression ISO RGD:732874 6480464 Lithocholic Acid results in decreased expression of NR0B2 mRNA CTD PMID:20359477 lithocholic acid multiple interactions ISO RGD:732874 6480464 [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of NR0B2 mRNA CTD PMID:20359477 lithocholic acid increases expression ISO RGD:621032 6480464 Lithocholic Acid results in increased expression of NR0B2 mRNA CTD PMID:20888898 Loratadine increases expression EXP 6480464 Loratadine results in increased expression of NR0B2 mRNA CTD PMID:15342952 LY294002 multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of NR0B2 mRNA] CTD PMID:25712622 MeIQx decreases expression EXP 6480464 2-amino-3 more ... CTD PMID:20816883 menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of NR0B2 mRNA CTD PMID:23410634 metformin decreases expression ISO RGD:732874 6480464 Metformin results in decreased expression of NR0B2 mRNA CTD PMID:24428821 methoxsalen decreases expression ISO RGD:621032 6480464 Methoxsalen results in decreased expression of NR0B2 mRNA CTD PMID:28552422 methoxsalen multiple interactions EXP 6480464 VDR protein affects the reaction [Methoxsalen results in increased expression of NR0B2 protein] CTD PMID:30419252 methoxsalen increases expression EXP 6480464 Methoxsalen results in increased expression of NR0B2 protein CTD PMID:30419252 methylmercury chloride multiple interactions ISO RGD:621032 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of NR0B2 mRNA CTD PMID:30744511 methylmercury(1+) decreases expression ISO RGD:621032 6480464 methylmercury II results in decreased expression of NR0B2 mRNA CTD PMID:17905399 monosodium L-glutamate decreases expression ISO RGD:732874 6480464 Sodium Glutamate results in decreased expression of NR0B2 mRNA CTD PMID:19001666 monosodium L-glutamate multiple interactions ISO RGD:732874 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of NR0B2 mRNA CTD PMID:19001666 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [fipronil co-treated with DEET] results in increased expression of NR0B2 mRNA CTD PMID:27091632 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:621032 6480464 Ethylnitrosourea results in increased mutagenesis of NR0B2 gene CTD PMID:16495775 N-nitrosodiethylamine multiple interactions ISO RGD:621032 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NR0B2 mRNA CTD PMID:17602206 N-nitrosodiethylamine decreases expression ISO RGD:621032 6480464 Diethylnitrosamine results in decreased expression of NR0B2 mRNA CTD PMID:19638242 N-nitrosodimethylamine decreases expression ISO RGD:621032 6480464 Dimethylnitrosamine results in decreased expression of NR0B2 mRNA CTD PMID:17072980 N-nitrosomorpholine decreases expression ISO RGD:621032 6480464 N-nitrosomorpholine results in decreased expression of NR0B2 mRNA CTD PMID:19716841 nickel dichloride decreases expression EXP 6480464 nickel chloride results in decreased expression of NR0B2 mRNA CTD PMID:17547211 O-methyleugenol decreases expression EXP 6480464 methyleugenol results in decreased expression of NR0B2 mRNA CTD PMID:32234424 obeticholic acid multiple interactions ISO RGD:621032 15036816 Obeticholic acid inhibits the reaction [ethanol decreases expression of Nr0b2 protein in liver and intestine] RGD obeticholic acid increases expression ISO RGD:732874 6480464 obeticholic acid results in increased expression of NR0B2 mRNA, obeticholic acid results in increased expression of NR0B2 protein CTD PMID:26655953 obeticholic acid increases expression EXP 6480464 obeticholic acid results in increased expression of NR0B2 mRNA CTD PMID:15911693 , PMID:27939613 obeticholic acid multiple interactions ISO RGD:621032 6480464 NR0B2 protein affects the reaction [obeticholic acid inhibits the reaction [JUND protein binds to TIMP1 promoter]] more ... CTD PMID:15860571 more ... obeticholic acid increases expression ISO RGD:621032 6480464 obeticholic acid results in increased expression of NR0B2 mRNA, obeticholic acid results in increased expression of NR0B2 protein CTD PMID:15644430 more ... obeticholic acid multiple interactions EXP 6480464 obeticholic acid promotes the reaction [PRMT2 protein binds to NR0B2 promoter] CTD PMID:15911693 oleic acid decreases expression EXP 6480464 Oleic Acid results in decreased expression of NR0B2 mRNA CTD PMID:30611723 oleic acid multiple interactions EXP 6480464 [Farnesol analog co-treated with Oleic Acid] results in decreased expression of NR0B2 mRNA more ... CTD PMID:30611723 paracetamol multiple interactions ISO RGD:732874 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NR0B2 mRNA more ... CTD PMID:17585979 , PMID:29943110 paracetamol decreases expression ISO RGD:732874 6480464 Acetaminophen results in decreased expression of NR0B2 mRNA CTD PMID:29943110 paracetamol affects response to substance ISO RGD:732874 6480464 NR0B2 protein affects the susceptibility to Acetaminophen CTD PMID:29943110 paracetamol affects expression ISO RGD:732874 6480464 Acetaminophen affects the expression of NR0B2 mRNA CTD PMID:17562736 Paxilline increases expression EXP 6480464 paxilline results in increased expression of NR0B2 mRNA CTD PMID:32123961 Paxilline multiple interactions EXP 6480464 [Bexarotene co-treated with paxilline] results in increased expression of NR0B2 mRNA, [CD 3254 co-treated with paxilline] results in increased expression of NR0B2 mRNA CTD PMID:32123961 PD 0325901 decreases expression EXP 6480464 PD 0325901 results in decreased expression of NR0B2 mRNA CTD PMID:24819614 pentamidine increases expression EXP 6480464 Pentamidine results in increased expression of NR0B2 mRNA CTD PMID:15342952 perfluorononanoic acid decreases expression EXP 6480464 perfluorononanoic acid results in decreased expression of NR0B2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of NR0B2 mRNA CTD PMID:21723365 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of NR0B2 mRNA CTD PMID:32253466 , PMID:32588087 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of NR0B2 mRNA CTD PMID:32253466 perhexiline increases expression EXP 6480464 Perhexiline results in increased expression of NR0B2 mRNA CTD PMID:15342952 , PMID:17175557 phenethyl caffeate multiple interactions ISO RGD:732874 6480464 [caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of NR0B2 mRNA, GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of NR0B2 mRNA] CTD PMID:28223344 phenobarbital decreases expression ISO RGD:732874 6480464 Phenobarbital results in decreased expression of NR0B2 mRNA CTD PMID:19270015 phenol decreases expression EXP 6480464 Phenol results in decreased expression of NR0B2 mRNA CTD PMID:17547211 phosphatidylcholine decreases abundance ISO RGD:732874 6480464 NR0B2 protein results in decreased abundance of Phosphatidylcholines CTD PMID:29416063 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NR0B2 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:732874 6480464 pirinixic acid results in increased expression of NR0B2 mRNA CTD PMID:17426115 more ... pirinixic acid multiple interactions ISO RGD:732874 6480464 NR0B2 protein promotes the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with pirinixic acid] results in increased expression of CYP4A14 mRNA], RXRA protein inhibits the reaction [pirinixic acid results in increased expression of NR0B2 mRNA] CTD PMID:19176532 , PMID:19593819 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of NR0B2 mRNA CTD PMID:17547211 pravastatin decreases expression ISO RGD:732874 6480464 Pravastatin results in decreased expression of NR0B2 mRNA CTD PMID:27225895 pravastatin decreases expression ISO RGD:621032 6480464 Pravastatin results in decreased expression of NR0B2 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:732874 6480464 [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of NR0B2 mRNA CTD PMID:20359477 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:732874 6480464 Pregnenolone Carbonitrile results in increased expression of NR0B2 mRNA CTD PMID:22982774 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:732874 6480464 Pregnenolone Carbonitrile results in decreased expression of NR0B2 mRNA CTD PMID:20359477 pyrazinecarboxamide multiple interactions ISO RGD:621032 6480464 obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of NR0B2 mRNA] CTD PMID:27255380 pyrazinecarboxamide decreases expression ISO RGD:621032 6480464 Pyrazinamide results in decreased expression of NR0B2 mRNA CTD PMID:27255380 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of NR0B2 mRNA CTD PMID:21632981 quercetin multiple interactions ISO RGD:732874 6480464 Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of NR0B2 mRNA] CTD PMID:25712622 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of NR0B2 mRNA] CTD PMID:25712622 resorcinol increases expression EXP 6480464 resorcinol results in increased expression of NR0B2 mRNA CTD PMID:22623647 resveratrol multiple interactions ISO RGD:621032 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of NR0B2 mRNA CTD PMID:25905778 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of NR0B2 mRNA CTD PMID:26044878 resveratrol multiple interactions EXP 6480464 PRKAA1 mutant form inhibits the reaction [resveratrol results in increased expression of NR0B2 mRNA] more ... CTD PMID:26044878 resveratrol increases expression ISO RGD:621032 6480464 resveratrol results in increased expression of NR0B2 mRNA CTD PMID:25905778 rifampicin increases expression EXP 6480464 Rifampin results in increased expression of NR0B2 mRNA CTD PMID:15670600 rotenone increases expression ISO RGD:621032 6480464 Rotenone results in increased expression of NR0B2 mRNA CTD PMID:28374803 S-adenosyl-L-homocysteine decreases abundance ISO RGD:732874 6480464 NR0B2 protein results in decreased abundance of S-Adenosylhomocysteine CTD PMID:29416063 S-adenosyl-L-methioninate increases abundance ISO RGD:732874 6480464 NR0B2 protein results in increased abundance of S-Adenosylmethionine CTD PMID:29416063 S-adenosyl-L-methionine increases abundance ISO RGD:732874 6480464 NR0B2 protein results in increased abundance of S-Adenosylmethionine CTD PMID:29416063 Salidroside multiple interactions ISO RGD:732874 6480464 rhodioloside inhibits the reaction [furan results in increased expression of NR0B2 mRNA] CTD PMID:32251705 senecionine decreases expression ISO RGD:621032 6480464 senecionine results in decreased expression of NR0B2 mRNA CTD PMID:24641316 senecionine decreases expression ISO RGD:732874 6480464 senecionine results in decreased expression of NR0B2 mRNA CTD PMID:31606820 sertraline increases expression EXP 6480464 Sertraline results in increased expression of NR0B2 mRNA CTD PMID:15342952 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of NR0B2 mRNA CTD PMID:25895662 silver atom decreases expression EXP 6480464 Silver results in decreased expression of NR0B2 mRNA CTD PMID:26014281 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of NR0B2 mRNA CTD PMID:26014281 sirtinol multiple interactions EXP 6480464 sirtinol inhibits the reaction [resveratrol results in increased expression of NR0B2 mRNA] CTD PMID:26044878 sodium arsenite increases expression ISO RGD:732874 6480464 sodium arsenite results in increased expression of NR0B2 mRNA CTD PMID:25610880 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of NR0B2 mRNA CTD PMID:29301061 sodium dichromate increases expression ISO RGD:621032 6480464 sodium bichromate results in increased expression of NR0B2 mRNA CTD PMID:25993096 sotalol decreases expression EXP 6480464 Sotalol results in decreased expression of NR0B2 mRNA CTD PMID:15342952 , PMID:17175557 sotalol increases expression EXP 6480464 Sotalol results in increased expression of NR0B2 mRNA CTD PMID:17175557 stigmasterol multiple interactions ISO RGD:732874 6480464 Stigmasterol promotes the reaction [GW 4064 results in increased expression of NR0B2 mRNA] CTD PMID:30245210 streptozocin multiple interactions ISO RGD:621032 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of NR0B2 mRNA CTD PMID:25905778 streptozocin multiple interactions ISO RGD:732874 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of NR0B2 protein CTD PMID:29382564 sumatriptan decreases expression EXP 6480464 Sumatriptan results in decreased expression of NR0B2 mRNA CTD PMID:15342952 tamoxifen affects expression ISO RGD:732874 6480464 Tamoxifen affects the expression of NR0B2 mRNA CTD PMID:20937368 tamoxifen multiple interactions EXP 6480464 Tamoxifen inhibits the reaction [ESR1 protein binds to NR0B2 protein] CTD PMID:23665804 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of NR0B2 mRNA CTD PMID:15342952 , PMID:17175557 tamoxifen increases expression ISO RGD:732874 6480464 Tamoxifen results in increased expression of NR0B2 mRNA CTD PMID:17555576 taurocholic acid increases expression EXP 6480464 Taurocholic Acid results in increased expression of NR0B2 mRNA CTD PMID:18706437 tert-butyl hydroperoxide affects expression EXP 6480464 tert-Butylhydroperoxide affects the expression of NR0B2 mRNA CTD PMID:23410634 testosterone affects metabolic processing ISO RGD:732874 6480464 NR0B2 protein affects the metabolism of Testosterone CTD PMID:17289919 tetrachloromethane decreases expression ISO RGD:732874 6480464 Carbon Tetrachloride results in decreased expression of NR0B2 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression ISO RGD:621032 6480464 Carbon Tetrachloride results in decreased expression of NR0B2 mRNA CTD PMID:31150632 , PMID:32380060 tetrachloromethane multiple interactions ISO RGD:621032 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NR0B2 mRNA] CTD PMID:31150632 thioacetamide decreases expression ISO RGD:621032 6480464 Thioacetamide results in decreased expression of NR0B2 mRNA CTD PMID:23411599 thioridazine increases expression EXP 6480464 Thioridazine results in increased expression of NR0B2 mRNA CTD PMID:17175557 Tributyltin oxide increases expression ISO RGD:621032 6480464 bistri-n-butyltinoxide results in increased expression of NR0B2 mRNA CTD PMID:17553608 trichloroethene decreases expression ISO RGD:732874 6480464 Trichloroethylene results in decreased expression of NR0B2 mRNA CTD PMID:25055964 triphenyl phosphate multiple interactions ISO RGD:732874 6480464 [tris1 more ... CTD PMID:29112739 Triptolide multiple interactions ISO RGD:732874 6480464 Lipopolysaccharides promotes the reaction [triptolide results in decreased expression of NR0B2 mRNA] CTD PMID:30633930 Triptolide decreases expression ISO RGD:732874 6480464 triptolide results in decreased expression of NR0B2 mRNA CTD PMID:30633930 urethane increases expression EXP 6480464 Urethane results in increased expression of NR0B2 mRNA CTD PMID:28818685 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of NR0B2 mRNA CTD PMID:18706437 , PMID:25055961 ursodeoxycholic acid increases expression ISO RGD:732874 6480464 Ursodeoxycholic Acid results in increased expression of NR0B2 mRNA CTD PMID:25582706 ursodeoxycholic acid increases expression ISO RGD:621032 6480464 Ursodeoxycholic Acid results in increased expression of NR0B2 mRNA CTD PMID:16764892 , PMID:21274875 valproic acid affects expression ISO RGD:732874 6480464 Valproic Acid affects the expression of NR0B2 mRNA CTD PMID:17292431 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of NR0B2 mRNA CTD PMID:17175557 vancomycin multiple interactions ISO RGD:732874 6480464 [Vancomycin co-treated with Imipenem] results in increased expression of NR0B2 mRNA CTD PMID:24657338 zaragozic acid A decreases expression ISO RGD:732874 6480464 squalestatin 1 results in decreased expression of NR0B2 mRNA CTD PMID:27225895 zaragozic acid A decreases expression ISO RGD:621032 6480464 squalestatin 1 results in decreased expression of NR0B2 mRNA CTD PMID:27225895 zimeldine increases expression EXP 6480464 Zimeldine results in increased expression of NR0B2 mRNA CTD PMID:17175557 zinc acetate multiple interactions ISO RGD:732874 6480464 [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] promotes the reaction [RXRA protein binds to NR0B2 promoter], [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] which results in increased expression of NR0B2 mRNA CTD PMID:26241054
